Diametric Capital, LP Ptc Therapeutics, Inc. Transaction History

Diametric Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $299,524 - $376,433	-6,596 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $5,320 - $6,872	125 Added 1.93%	6,596 $335,000
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $940,348 - $1.72 Million	-29,050 Reduced 81.78%	6,471 $289,000
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $1.14 Million - $1.78 Million	35,521 New	35,521 $1.71 Million
Q3 2019 Nov 13, 2019	SELL	$33.82 - $48.17 $1.51 Million - $2.14 Million	-44,518 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $1.58 Million - $2 Million	44,518 New	44,518 $2 Million

221

78M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.14B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.